Use access key #2 to skip to page content.
$23.12 -0.88 (-3.67%)
1/9/2009 4:00 PM

Alnylam Pharmaceuticals, Inc. (ALNY)

CAPS Rating:
***

A biopharmaceutical company developing novel therapeutics based on RNA interference, which is a naturally occurring biological pathway within cells for selectively silencing and regulating specific genes.

View All Commentary (ALNY)

Recs

0

Avatar nrkrishna (22.87) Submitted: 8/27/08 1:35 PM : Outperform Start Price: $28.87 ALNY Score: 10.82

nice pullback - speculative pick

Report this Post Replies: 0 | Reply | Permalink

Featured Broker Partners

Sponsored Links